Galactose Inhibits the Translation of Erg1 that Enhances the Antifungal Activities of Azoles Against Candida albicans
Open Access
- 5 August 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 799
Abstract
Background/Objectives: The diminished efficacy of azoles in treating fungal infections is attributed to the emergence of resistance among pathogenic fungi. Employing a synergistic approach with other compounds to enhance the antifungal activity of azoles has shown promise, yet the availability of clinically valuable adjuvants for azoles and allylamines remains limited. Studies have demonstrated that the human host environment provides multiple carbon sources, which can influence the susceptibility of C. albicans to antifungal agents. Therefore, a comprehensive investigation into the mechanisms by which carbon sources modulate the susceptibility of C. albicans to azoles may uncover a novel pathway for enhancing the antifungal efficacy of azoles. Methods: This study explored the impact of various carbon sources on the antifungal efficacy of azoles through methodologies including minimum inhibitory concentration (MIC) assessments, super-MIC growth (SMG) assays, disk diffusion tests, and spot assays. Additionally, the mechanism by which galactose augments the antifungal activity of azoles was investigated using a range of experimental approaches, such as gene knockout and overexpression techniques, quantitative real-time PCR (qRT-PCR), Western blot analysis, and cycloheximide (CHX) chase experiments. Results: This study observed that galactose enhances the efficacy of azoles against C. albicans by inhibiting the translation of Erg1. This results in the suppression of Erg1 protein levels and subsequent inhibition of ergosterol biosynthesis in C. albicans. Conclusions: In C. albicans, the translation of Erg1 is inhibited when galactose is utilized as a carbon source instead of glucose. This novel discovery of galactose’s inhibitory effect on Erg1 translation is expected to enhance the antifungal efficacy of azoles.Keywords
Funding Information
- National Natural Science Foundation of China (82020108032, 202101070007-E00094)
- Innovation Program of Shanghai Municipal Education Commission (82020108032, 202101070007-E00094)
This publication has 79 references indexed in Scilit:
- Otilonium Bromide Exhibits Potent Antifungal Effects by Blocking Ergosterol Plasma Membrane Localization and Triggering Cytotoxic Autophagy in Candida AlbicansAdvanced Science, 2024
- Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategiesAdvanced Drug Delivery Reviews, 2023
- History of the development of antifungal azoles: A review on structures, SAR, and mechanism of actionBioorganic Chemistry, 2020
- Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal designBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2020
- Hsp90 mediates the crosstalk between galactose metabolism and cell morphology pathways in yeastCurrent Genetics, 2016
- Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulenceJournal of Microbiology, 2013
- Adaptive stress response to menadione-induced oxidative stress in Saccharomyces cerevisiae KNU5377Journal of Microbiology, 2011
- Mutations on CaENO1 in Candida albicans inhibit cell growth in the presence of glucoseJournal of Biomedical Science, 2006
- Under cover: causes, effects and implications of Hsp90‐mediated genetic capacitanceBioEssays, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001